Cyberattacks against accounting software firm Wolters Kluwer and the City of Baltimore in May showed how the newest wave of malicious hacking can have significant, often...Technologyread more
The European parliamentary election is the second largest democratic exercise in the world.Europe Newsread more
Biden had criticized Kim Jong Un as a "dictator" and a "tyrant" at a recent rally in Philadelphia. North Korean state media responded by calling Biden a "fool of low IQ" among...Politicsread more
Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
When commercial real estate investor Manny Khoshbin spent $2.2 million on the fastest production car in the world, he had no idea it would very quickly also become the...Autosread more
Johnson & Johnson CEO Alex Gorsky told CNBC on Monday that the health-care giant spoke with "the administration around" President-elect Donald Trump regarding the state of the U.S. health-care system.
"And the kinds of things we're talking about is how can we take what I believe is one of the very best health-care systems in the world and how can we make it even better? How can we make changes, recognizing the challenges, economic pressures, regulatory pressures, but keep essential elements like innovation through better integration?" Gorsky said on CNBC's "Power Lunch. "
Gorsky's comments, speaking at the 35th annual JPMorgan health-care conference in San Francisco, come after Trump said he intends to repeal the Affordable Care Act, popularly known as Obamacare.
Last month Trump also blasted the entire drug industry in an interview with Time magazine, sending shares of pharmaceutical and biotechnology companies lower.
"I'm going to bring down drug prices," the president-elect said. "I don't like what has happened with drug prices."
Despite Trump's rhetoric around the drug industry, Johnson & Johnson's stock is up so far in 2017. Gorksy said the company is pleased with its performance overall, but far from satisfied.
"The underlying driver in all that is about innovation. It is about execution and it is about delivering on our commitments," he said. "Over the past four years, we've been able to launch 15 brand new pharmaceutical products that have been great for patients, but also have been a real driver in our business."
Johnson & Johnson is currently negotiating a deal to acquire Swiss biotechnology company Actelion. On Friday, a Reuters report said the two companies have asked Switzerland's takeover board about the viability of a complicated takeover deal.
Gorksy said the company will look to make more deals in 2017. "We're always a deal maker. Take a look at us historically over the 20, 10, five years," he said.